Brazilian pharmaceutical company Hypera SA has acquired 12 over-the-counter (OTC) and prescription brands in Latin America from France’s Sanofi SA for $190.3 million, the company said in a securities filing.
Among the brands acquired are mouth wash Cepacol and antipyretic AAS. Hypera is also buying drugs to treat epilepsy. Hypera has recently bought Takeda’s portfolio in Brazil.
Source: Reuters.com